USPTO serial 50016358
N/A
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with N/A?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joel R. Feldman
Joel R. Feldman Greenberg Traurig, LLP3333 Piedmont Rd NE, Suite 2500Atlanta, GA 30305United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, preparations for the prevention and treatment of cancers; pharmaceutical preparations, namely, platelet stimulating factors; pharmaceutical cardiovascular preparations; Pharmaceutical preparations for the treatment of cardiovascular disease, urological disorders, gastrointestinal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, obesity and respiratory diseases, fungal disorders; pharmaceutical preparations, namely anti-inflammatory analgesics; pharmaceutical preparations, namely, pharmaceutical preparations for treating high cholesterol, pharmaceutical preparations for the prevention and treatment of smoking habits and addictions; Pharmaceutical preparations for the treatment of diabetes, cancer; diagnostic reagents for scientific or medical research use; scientific and medical compounds, namely, protein kinases and phosphatases; Pharmaceutical preparations for the prevention and/or treatment of cancer, carcinomas and sarcomas; pharmaceutical preparations for the prevention and/or treatment of cancerous tumors; Pharmaceutical preparations for the treatment of pains, fever, angina, otorhinolaryngology, gastric and liver illnesses, heart illnesses, arterial and venous illnesses, rheumatic illnesses, namely osteoarthritis, rheumatoid arthritis, lupus, ankylosing spondylitis, Sjogren's syndrome, gout, fibromyalgia, and polymyalgia rheumatica; general anesthetics, analgesics, frostbite salve for pharmaceutical purposes, hemorrhoid preparations, pharmaceutical preparations for the treatment of headaches, salts for medicated baths, mouthwashes for medical purposes, tranquillizers, sedatives, tobacco free cigarettes for smoking cessation treatments, medicines for alleviating constipation, contraceptives chemicals, radiological contrast substances for medical purposes, diagnostic preparations for medical purposes, namely lubricants and gels for ultrasound and gynecological diagnostic procedures; drugs for the treatment of pain, fever, angina otorhinolaryngology, gastric and liver illnesses, heart illnesses, arterial and venous illnesses, and rheumatic illnesses, namely osteoarthritis, rheumatoid arthritis, lupus, ankylosing spondylitis, Sjogren's syndrome, gout, fibromyalgia, and polymyalgia rheumatica; mineral water; Pharmaceutical preparations for the treatment of smooth muscle disorders, namely stroke, Parkinson's disease, multiple sclerosis, Huntington's disease, Creutzfeldt Jakob disease, Amyotrophic lateral sclerosis, muscular dystrophy, inflammatory myopathies, and dystonias, headaches, wrinkles, hyperhidrosis, sports injuries, namely, injured or torn skin, muscle, ligaments or bone, tremors, namely, spasmodic smooth, striated or cardiac muscles; pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labor pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, bladder pain; pharmaceutical preparations for the treatment of cerebral palsy; Pharmaceutical preparations and substances, namely anti-infectives, anti-bacterials, antibiotics, antivirals, antidiabetic preparations, cardiovascular preparations, hemostatic agents, pharmaceutical preparations and substances for the treatment of cancer, HIV, obesity, and respiratory and urologic disorders and diseases; pharmaceutical preparations and substances for the treatment of acute ischemic stroke and traumatic brain injury (TBI), cerebral vasodilators; Prescription pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system, peripheral nervous system, namely diabetic nerve problems, Guillaume-Barr syndrome, carpal tunnel syndrome, thoracic outlet syndrome, complex regional pain and brachial plexus injuries, cardiovascular system, gastro-intestinal system; pharmaceutical preparations and substances for treatment of chronic pain, general anesthetics; pharmaceutical preparations and substances for use in oncology; prescription pharmaceutical preparations and substances for the treatment and prevention of diabetes; Pharmaceutical preparation and substances, namely hematinics which increase the hemoglobin content of the blood | ACTIVE | — |
| 009 | Downloadable artificial intelligence software for pharmaceutical research and development; conducting research, development and evaluations in the field of pharmaceutical formulations. | ACTIVE | — |
| 042 | Non-downloadable artificial intelligence software for pharmaceutical research and development; conducting research, development and evaluations in the field of pharmaceutical formulations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 27, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 27, 2026 | NWAP | NEW APPLICATION ENTERED | — |